Low levels of TSC22 enhance tumorigenesis by inducing cell proliferation in colorectal cancer
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 497 (4) , 1062-1067
Abstract
No abstract availableKeywords
Funding Information
- ational Natural Science Foundation of China (81672347)
This publication has 14 references indexed in Scilit:
- Growth pattern of colorectal liver metastasis as a marker of recurrence riskClinical & Experimental Metastasis, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Crucial Role of TSC-22 in Preventing the Proteasomal Degradation of p53 in Cervical CancerPLOS ONE, 2012
- Transforming growth factor‐β‐stimulated clone‐22 is a negative‐feedback regulator of Ras / Raf signaling: Implications for tumorigenesisCancer Science, 2011
- TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancerBreast Cancer Research and Treatment, 2008
- Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancerGenome Biology, 2007
- The Putative Tumor Suppressor Tsc-22 is Downregulated Early in Chemically Induced Hepatocarcinogenesis and may be a Suppressor of Gadd45bToxicological Sciences, 2007
- Differential expression of TGFβ‐stimulated clone 22 in normal prostate and prostate cancerInternational Journal of Cancer, 2005
- Peroxisome Proliferator-activated Receptor γ and Transforming Growth Factor-β Pathways Inhibit Intestinal Epithelial Cell Growth by Regulating Levels of TSC-22Journal of Biological Chemistry, 2003
- Cloning of rat Sertoli cell follicle-stimulating hormone primary response complementary deoxyribonucleic acid: regulation of TSC-22 gene expression.Endocrinology, 1994